Erin O'Connor
@Fairmount Funds Management Llc
Latest period2024 - Q3ReportedManaged Assets$1.233BTotal holdings15
Assets growth rate39.34%Assets growth rate (2-Q avg)17.91%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Fairmount Funds Management Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 15 positions.
Assets under management
The assets under management (AUM) of Fairmount Funds Management Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.233B in assets, with a quarterly growth rate of 39.34% and a 2-quarter average growth rate of 17.91%. The portfolio is managed by Erin O'Connor, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
PTGXProtagonist Therapeutics Inc
| 0% | $32.29M 931,890 shares@ $34.66 avg price | Exited |
TERNTerns Pharmaceuticals Inc
| 0% | $5.101M 748,996 shares@ $6.82 avg price | Exited |